Does Bill Ackman Have a 'Hate-On for Allergan?

The video discusses the business dynamics between Allergan, Valiant, and Actavis, focusing on Allergan's preference for Actavis over Valiant due to concerns about R&D cuts. Bill Ackman's role in the potential acquisition by Valiant is highlighted, along with his alternative plan involving Zoetis. The video also explores the potential outcomes of these business deals and their implications for the companies involved.

What is the significance of the $60 billion price mentioned in relation to Allergan?

Why is Allergan willing to engage with activists despite fending off Valiant?

How does Allergan perceive Actavis compared to Valiant?

What are the concerns regarding Bill Ackman's intentions with Allergan?

What is Bill Ackman's Plan B if he does not succeed with Valiant?